(Q69304601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

The efficacy and safety of GR38032F in the prophylaxis of ifosfamide-induced nausea and vomiting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

author name string

J A Green

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

S W Watkin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

P Hammond

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

J Griggs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

T Challoner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

30 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

137-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00263137

30 September 2019

exact match

0 references

cites work

Emesis due to cancer chemotherapy: Results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting

1 reference

12 December 2020

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

1 reference

12 December 2020

The control of chemotherapy-induced emesis

1 reference

12 December 2020

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

12 December 2020

Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.

1 reference

12 December 2020

The effect of administration rate on cisplatin-induced emesis

1 reference

12 December 2020

The comparative pharmacology of cyclophosphamide and ifosfamide

1 reference

12 December 2020

Metoclopramide. A review of antiemetic trials.

1 reference

12 December 2020

Prediction of ifosfamide/mesna associated encephalopathy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00263137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2525078%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 September 2019

0 references

1 reference